98 related articles for article (PubMed ID: 3874685)
1. Association of differentiated thyroid carcinoma with HLA-DR7.
Sridama V; Hara Y; Fauchet R; DeGroot LJ
Cancer; 1985 Sep; 56(5):1086-8. PubMed ID: 3874685
[TBL] [Abstract][Full Text] [Related]
2. Strong association between an HLA-DR antigen and thyroid carcinoma.
Panza N; Del Vecchio L; Maio M; De Felice M; Lombardi G; Minozzi M; Zappacosta S
Tissue Antigens; 1982 Aug; 20(2):155-8. PubMed ID: 6814009
[TBL] [Abstract][Full Text] [Related]
3. [HLA and thyroid cancer].
Dralle H; Robin-Winn M; Reilmann L; Laue A; Török M
Klin Wochenschr; 1986 Jun; 64(11):522-5. PubMed ID: 3459939
[TBL] [Abstract][Full Text] [Related]
4. Immunogenetic and immunologic studies of differentiated thyroid cancer.
Juhasz F; Boros P; Szegedi G; Balazs G; Suranyi P; Kraszits E; Stenszky V; Farid NR
Cancer; 1989 Apr; 63(7):1318-26. PubMed ID: 2784072
[TBL] [Abstract][Full Text] [Related]
5. Lack of association of HLA with thyroid cancer. An effect of iodine sufficiency and safe environment?
Larsen B; Thompson C; Kwan A; Farid NR
Tissue Antigens; 1986 Nov; 28(5):298-300. PubMed ID: 3824363
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR and differentiated thyroid cancer. Lack of association with the nonmedullary types and possible association with the medullary type.
Weissel M; Kainz H; Hoefer R; Mayr WR
Cancer; 1988 Dec; 62(12):2486-8. PubMed ID: 3191450
[TBL] [Abstract][Full Text] [Related]
7. Familial occurrence of differentiated, nonmedullary thyroid carcinoma.
Ozaki O; Ito K; Kobayashi K; Suzuki A; Manabe Y; Hosoda Y
World J Surg; 1988 Aug; 12(4):565-71. PubMed ID: 3048001
[No Abstract] [Full Text] [Related]
8. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
[TBL] [Abstract][Full Text] [Related]
9. HLA and thyroid carcinoma.
Ahuja S; Hoppe I; von Keyserlingk H; Ernst H
Exp Clin Endocrinol; 1992; 99(3):134-6. PubMed ID: 1526261
[TBL] [Abstract][Full Text] [Related]
10. Evidence of a strong, positive association between atopy and the HLA class II alleles DR4 and DR7.
Aron Y; Desmazes-Dufeu N; Matran R; Polla BS; Dusser D; Lockhart A; Swierczewski E
Clin Exp Allergy; 1996 Jul; 26(7):821-8. PubMed ID: 8842557
[TBL] [Abstract][Full Text] [Related]
11. Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomas.
Porto T; Coelho I; Boavida J; Pereira C; Nunes JM; Mendonça D; Martins B; Sobrinho LG; Leite V
Clin Endocrinol (Oxf); 2006 Feb; 64(2):179-83. PubMed ID: 16430717
[TBL] [Abstract][Full Text] [Related]
12. DNA content in radiation-associated thyroid cancer.
Komorowski RA; Deaconson TF; Vetsch R; Cerletty JM; Wilson SD
Surgery; 1988 Dec; 104(6):992-6. PubMed ID: 3194850
[TBL] [Abstract][Full Text] [Related]
13. Both class I and class II HLA antigens are thyroid cancer susceptibility factors.
Rigopoulou D; Martinez-Laso J; Martinez-Tello F; Alcaide JF; Benmamar D; Hawkins F; Arnaiz-Villena A
Tissue Antigens; 1994 May; 43(5):281-5. PubMed ID: 7940496
[TBL] [Abstract][Full Text] [Related]
14. [Idiopathic nephrotic syndrome and the HLA allele. Prevalence of age-related DR7].
Laurent J; Belghiti D; Ansquer JC; Cambon-Thomsen A; Bracq C; Reinert P; Lagrue G
Rev Med Interne; 1985 Mar; 6(2):116-20. PubMed ID: 3873669
[TBL] [Abstract][Full Text] [Related]
15. HLA class II expression in well differentiated thyroid carcinoma: correlation with clinicopathological features.
Knoll MR; Schwab M; Oestreich K; Rumstadt B; Hagmüller E
J Exp Clin Cancer Res; 1997 Jun; 16(2):177-82. PubMed ID: 9261744
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR7 association with African Burkitt's lymphoma.
Jones EH; Biggar RJ; Nkrumah FK; Lawler SD
Hum Immunol; 1985 Jul; 13(3):211-7. PubMed ID: 3874196
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR association in papillary thyroid carcinoma.
Amoli MM; Yazdani N; Amiri P; Sayahzadeh F; Haghpanah V; Tavangar SM; Amirzargar A; Ghaffari H; Nikbin B; Larijani B; Mostaan LV; Bazzaz JT
Dis Markers; 2010; 28(1):49-53. PubMed ID: 20164547
[TBL] [Abstract][Full Text] [Related]
18. Well differentiated thyroid carcinoma is associated with human lymphocyte antigen D-related 11 in Eastern Hungarians: a case of changing circumstances.
Juhasz F; Kozma L; Stenszky V; Gyory F; Luckas G; Farid NR
Cancer; 2005 Oct; 104(8):1603-8. PubMed ID: 16121403
[TBL] [Abstract][Full Text] [Related]
19. HLA-G 3' untranslated region polymorphic sites associated with increased HLA-G production are more frequent in patients exhibiting differentiated thyroid tumours.
de Figueiredo-Feitosa NL; Martelli Palomino G; Cilião Alves DC; Mendes Junior CT; Donadi EA; Maciel LM
Clin Endocrinol (Oxf); 2017 Apr; 86(4):597-605. PubMed ID: 27914217
[TBL] [Abstract][Full Text] [Related]
20. Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer.
Nunes LM; Ayres FM; Francescantonio IC; Saddi VA; Avelino MA; Alencar Rde C; Silva RC; Meneghini AJ; Wastowski IJ
Hum Immunol; 2013 Apr; 74(4):447-51. PubMed ID: 23261411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
